protocol INtroDUctIoNIn vitro methods to model human development and disease are part of a rapidly expanding field of stem cell biology with major therapeutic implications 1 . Organoid protocols stand at the forefront of these technologies, as these 3D approaches more accurately reproduce in vivo developmental events leading to more precise in vitro models 2,3 . Organoids have already been developed for several organ systems, including retina 4 , intestine 5 , thyroid 6 , liver 7 , pituitary 8 , inner ear 9 , kidney 10-12 and brain 13 . However, only a handful of methods exist for generating such tissues from human pluripotent stem cells (hPSCs) [13][14][15][16][17] . In this protocol, we describe the methodology that was recently published for generating brain organoid tissues from hPSCs 13 .
Development of the protocolThe method described here builds on an extensive foundation of protocols for neural differentiation, 3D tissue culture and tissue engineering. Cerebral organoids develop through intrinsic selforganizing processes upon timely application of components and culture environments that had previously been described individually. Thus, the method is an amalgamation of previous methods, combined in a specific manner to address two main objectives: (i) the establishment of neural identity and differentiation and (ii) the recapitulation of 3D structural organization.
Establishment of brain identityThe first goal of the protocol is induction and differentiation of neural tissue. This involves identification of media formulations and additives to drive neural identity and to stimulate brain development in vitro. To achieve this, a number of medium formulations were tested at various time points. Rather than describing the multitude of tested combinations, we focus here on the successful outcome.Neural tissue develops in vivo from a germ layer called the ectoderm 18 . Similarly, PSCs in vitro can be stimulated to develop germ layers, including ectoderm, within aggregates called embryoid bodies (EBs) 19 . A number of previous studies have described successful differentiation of EBs in embryonic stem cell (ESC) medium with decreased basic fibroblast growth factor (bFGF) 20 and high-dose rho-associated protein kinase (ROCK) inhibitor to limit cell death 21 . Similarly, cerebral organoids develop from EBs grown initially in ESC medium with low bFGF and ROCK inhibitor.Subsequent neural induction of EBs follows a minimal medium formulation very similar to that established by Zhang et al. 22,23 for the induction of neural rosettes, a 2D polarized organization of neuroepithelial cells. However, for the generation of cerebral organoids, EBs are kept in suspension, leading to uniform neural ectoderm formation along the outer surface of EBs, whereas inner non-neural mesendodermal tissues do not develop.Neural ectoderm in vivo establishes radially organized neuroepithelia that expand to form various brain structures. Similarly, organoids placed in a differentiation medium that supports both neural progenitors and their p...